NCT06323603

Brief Summary

The biomonitoring study aims to evaluate genotoxic damage and other parameters of exposure in different occupational exposed populations that work directly with different plastics.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Geographic Reach
2 countries

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 30, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

March 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 21, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

March 25, 2024

Status Verified

March 1, 2024

Enrollment Period

11 months

First QC Date

March 14, 2024

Last Update Submit

March 21, 2024

Conditions

Keywords

BiomonitoringGenotoxic damageMicro and nanoplastic

Outcome Measures

Primary Outcomes (5)

  • Characterization of macro and nanoplastics

    The characterization of macro and nanoplastics will be done by Raman spectrosmicroscopy and FTIR (From exhaled breath condensate, blood and urine)

    Up to 1 year

  • Genotoxic evaluation by the Micronucleus assay

    Blood and buccal cells will be collected from donors to check for the presence of genotoxic permanent damage

    Up to 1 year

  • Genotoxic evaluation by the Comet assay

    Blood will be analysed to check for the presence of genotoxic primary damage

    Up to 1 year

  • Cytokine release

    Plasma will be analysed to check for the presence of cytokines

    Up to 1 year

  • Microbiota analysis from feces by MinIOn

    Feces will be analysed to check for variations in microbiota in the exposed and control groups

    up to 1 year

Secondary Outcomes (1)

  • Analyses of surrogate biomarkers

    Up to 1 year

Study Arms (3)

1. Textile industry workers

Workers from the textile industry, that manufactures non-wovens fibers

Other: Micro and nanoplastic

2. Plastic Recycling Workers

Workers involved in recycling and waste management of plastic

Other: Micro and nanoplastic

3. Controls

Control group that will match the characteristics of grup 1 and 2

Interventions

Biological samples will be obtained to evaluate the different biomarkers selected

1. Textile industry workers2. Plastic Recycling Workers

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study aims to determine whether workers occupationally exposed to different plastics show increased genomic damage, changes in cytokine expression and/ or microbiota. Moreover, the levels of macro/microplastics in different body fluids will be characterized. Different European populations dedicated to the recycling of plastics and the production of non-woven textiles will be used, as well as a control group that will match according to the characteristics of the populations. At least 50 workers from each of the participating industries will be used to demonstrate a higher exposure MNPLs level and, therefore, an increased health risk.

You may qualify if:

  • Aged over 18 years.
  • Healthy subjects defined by the absence of evidence of any active or chronic disease following a detailed medical and surgical history, a complete physical examination including vital signs, 12-lead ECG, haematology, blood chemistry, and urine analysis.
  • Able to participate and willing to give written informed consent and to comply with the study restrictions.
  • Have been working at the company for the last 48 months

You may not qualify if:

  • Workers decline participation
  • Legal incapacity or inability to understand or comply with the requirements of the study.
  • Any hierarchical subordination to the PI
  • Clinically significant findings as determined by medical history taking, physical examination, ECG, and vital signs.
  • Submitted to X-ray in the three previous months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Textile industry

Helsinki, Finland

COMPLETED

Recycling company

Alicante, Spain

COMPLETED

Textile Industry

Alicante, Spain

COMPLETED

Control recruitment

Barcelona, Spain

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

blood, exhaled breath condensate, exfoliated buccal cells, urine and feces

Study Officials

  • Julia Catalan, Researcher

    FIOH

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alba Hernández, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 14, 2024

First Posted

March 21, 2024

Study Start

June 30, 2023

Primary Completion

June 1, 2024

Study Completion

September 1, 2024

Last Updated

March 25, 2024

Record last verified: 2024-03

Locations